Medindia5h
Diabetes Drug Semaglutide Reduces Heart Attacks and Strokes
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...
Medscape5h
Oral GLP-1 Receptor Antagonist Reduces CV Risk
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
The American Journal of Managed Care2h
SOUL Findings Highlight Cardiovascular Benefits Beyond Glycemic Control With Oral GLP-1
Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...
Trina Krug on MSN45m
What If You Want a GLP-1 Alternative That’s More Natural?
There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...
'Ozempic made our arms, bums and legs look like MELTED CANDLES': the terrifying new side effects rapidly emerging in young people taking weight-loss drugs
Plastic surgeons are reporting a surge in patients demanding 'dangerous' cosmetic operations due to the effects of losing a ...